This Startup Could Lead the Longevity Boom ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | A message from Market Jar
Dear Investor,
Joe Rogan just torched Big Pharma on air… and the timing couldn't be better. Why? Because a tiny biotech just stepped onto the scene — and it could be the reason Big Pharma's sweating. This company is leading a $100B+ revolution around peptides — powerful compounds used by elite athletes and billionaires to boost metabolism, reverse aging, and heal at the cellular level. They're backed by Saudi royalty, NFL superstars, and biohacking icons like Gary Brecka and Chris Bumstead. But here's the kicker: they're not just selling supplements. They've built a direct-to-consumer platform combining medical-grade peptides, telehealth, and AI-powered optimization — targeting the $77B longevity market. It's the perfect storm: massive market tailwinds, elite leadership, and first-mover advantage. And right now, they're still under the radar. That won't last long. Subscribe Now and get the full story here before Wall Street wakes up. By submitting your email address, you give Trading Whisperer permission to deliver the presentation or research you're requesting to your email inbox. As a bonus, you will also get a free subscription to our stock alerts newsletter, Trading Whisperer. You can unsubscribe at any time. Privacy Policy
Examples that we provide of share price increases pertaining to a particular Issuer from one referenced date to another represent an arbitrarily chosen time period and are no indication whatsoever of future stock prices for that Issuer and are of no predictive value. Our stock profiles are intended to highlight certain companies for YOUR further investigation; they are NOT stock recommendations or constitute an offer or sale of the referenced securities.
This message is a PAID ADVERTISEMENT for Vesalius Longevity Labs, Inc (Form D Filing) from Market Jar Media Inc. StockEarnings, Inc. has received a fixed fee of $7000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between May 12, 2025 and May 31, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Vesalius Longevity Labs, Inc (Form D Filing) or Market Jar Media Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Vesalius Longevity Labs, Inc (Form D Filing) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Vesalius Longevity Labs, Inc (Form D Filing).
Your privacy is very important to us. If you no longer wish to receive email from DailyOptionsSignals.com, please click Unsubscribe.
StockEarnings, Inc
33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA
W: 877.6.STOCKS
StockEarnings.com
Today's Bonus Content: 💰 Position Your Portfolio for Growth in the Trump Era 🚀
(By clicking the link above, you're choosing to opt in to receive insightful updates from Wealth Creation Investing + 2 free bonus subscriptions! Your privacy is important to us. You can unsubscribe anytime. See our privacy policy for details.) | | |
|
Tidak ada komentar:
Posting Komentar